pageInfo({
    time : "1261248428743"
  
	    , page : null
	  
	    , url : null
	  
	    , instrument : null
	  
	    , article : {
	        storyId : "USN3127353020080731"
	        , headline : "Option traders eye biotech stocks after ImClone news"
	        , keywords : "[Healthcare, Pharmaceuticals - diversified, Online Report text item, Investment trusts, Financials, Chemicals, Biotechnology, Pharmaceuticals (sub-industry), Pharmaceuticals and biotechnology, United States of America, Financial service providers, Canada]"
	        , tickers : "[AMGN.O, de;RHOF, IBB.A, IMCL.O, mx;AMGN, mx;BMY, ONXX.O, us;AMGN, us;AMLN, us;BMY, us;DNA, us;IBB, us;IMCL, us;ONXX, us;RHHQ, us;RHHV, de;RHO, de;OX1X, AMLN.O, ch;AMGN, ch;RO, de;API, de;APIF, de;APIS, de;APIX, de;BRM, de;BRMF, de;BRMS, de;BRMX, de;OX1, de;OX1F, de;OX1S, xt;RO, BMY.N]"
	    }
	    , channel : {
	        id : "54"
	        , name : "companyNews"
	        , title : "Company News"
	    }})